Recent Quotes (30 days)

You have no recent quotes
chg | %

Allergy Therapeutics plc  

(Public, LON:AGY)   Watch this stock  
Find more results for AGY
-1.01 (-3.00%)
Oct 20 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 19.50 - 39.50
Open     -
Vol / Avg. 0.00/341,731.00
Mkt cap 268.35M*
P/E     -
Div/yield     -
EPS 0.00*
Shares 603.97M
Beta     -
Inst. own     -
Sep 28, 2017
Full Year 2017 Allergy Therapeutics PLC Earnings Call
Sep 28, 2017
Full Year 2017 Allergy Therapeutics PLC Earnings Release (Estimated)

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -39.32% -3.87%
Operating margin -38.49% -2.96%
EBITD margin - 0.06%
Return on average assets -30.47% -4.36%
Return on average equity -54.34% -8.23%
Employees 506 -
CDP Score - -


Dominion Way
United Kingdom - Map
+44-1903-844700 (Phone)
+44-1903-844726 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Allergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.

Officers and directors

Manuel Llobet Chief Executive Officer, Executive Director
Age: 50
Nicolas Alexander Ulrich Wykeman Finance Director
Age: 51
Peter Sinclair Jensen Non-Executive Chairman of the Board
Age: 63
Jeff Barton Non-Executive Director
Tunde Otulana Non-Executive Independent Director
Age: 60
Stephen Rushworth Smith Senior Non-Executive Independent Director
Age: 61